The incidence of hypoxemia (SpO 2 < 90%), which was the primary outcome, was 34.4% (n = 56) in the COVID group and 24.5% (n = 40) in the control group; however, this difference did not reach statistical significance ( P = .068).
← all excerpts
Does previous COVID-19 severity affect propofol sedation safety during ERCP?: A prospective observational study.
1
0.0680
0.0680